Options information is delayed a minimum of 15 minutes, and is updated at least once every 15-minutes through-out the day. The screener displays probability calculations based on the delayed stock price at the time the strategy is updated. The new day's options data will start populating the...
View the most recent data and latest information on option chains for Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) at Nasdaq.com.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sarepta Therapeutics Inc (Symbol: SRPT),.
Bull or Bear, Seeking Alpha is thereMarkets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. Continue with Google Continue with Apple or Create Free Account By creating an account using any of the options above, you agree to the Terms of ...
SRPT Stock USD 103.06 3.80 3.56% Sarepta Therapeutics volume indicators tool provides the execution environment for running the Chaikin AD Line indicator and other technical functions against Sarepta Therapeutics. Sarepta Therapeutics value trend is the prevailing direction of the price over some defined ...
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial LOGIN Try Barchart for Free or Watchlist | Portfolio | Dashboard Stocks Options ETFs Futures Currencies Investing News Tools Learn Site News 1 Contact quotes Price Overview Performance ...
Options Trading Growth Stocks Biotech Investing Tech Stocks Quantitative Investing Learn Investing Resources Investing Education Investing Strategies Retirement Investing Stock Market Sectors Stock Market Holidays & Hours After Hours Trading Portfolio Management Cryptocurrency Dividend Investing Portfolio Strategy Fixed...
Stocks Sarepta Therapeutics (SRPT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now 4 days ago • Zacks Markets Relative Strength Alert For Sarepta Therapeutics 5 days ago • BNK Invest Markets First Week of SRPT April 17th Options Trading 6 days ago • BNK I...
Sarepta Therapeutics (NASDAQ:SRPT) Q1 results ($M): EXONDYS 51 sales: 16.3 (consensus: 13.9).Net Income: 84.1 (+240.6%): Non-GAAP Net Income: (33.0)...
Spreads Protection Strategies Straddles & Strangles Horizontal Spreads Butterfly Spreads Condor Strategies company News & Headlines Key Statistics SEC Filings Competitors Stock Comparison Insider Trades analysts Earnings Estimates Analyst Ratings financials Financial Summary Income Statement Balance Sheet Cash Flow...